CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,500 | $37.57 | $56K | 156,578 |
| 2018-06-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −500 | $39.40 | $20K | 156,078 |
| 2018-06-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,700 | $40.01 | $108K | 159,778 |
| 2018-06-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,700 | $40.79 | $69K | 158,078 |
| 2018-06-18 | Gallagher Carol Giltner Director | Sale | −2,100 | $44.68 | $94K | 110,592 |
| 2018-06-18 | Gallagher Carol Giltner Director | Sale | −400 | $45.29 | $18K | 110,192 |
| 2018-06-14 | MARCUS JOEL S Director | Grant or award | +1,500 | 8,500 | ||
| 2018-06-14 | MARCUS JOEL S Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2014-10-21 | MARCUS JOEL S Director | Purchase | +9,090 | $11.00 | $100K | 9,090 |
Page 29 of 29 · 569 trades